Influence of Sperm With Large Nuclear Vacuole on ICSI Outcomes
1 other identifier
interventional
200
1 country
1
Brief Summary
Current research on sperm morphology has been directed towards the dysmorphisms of the sperm head. A new technique based on the motile sperm organelle morphology examination (MSOME) allows the detection of sperm with large nuclear vacuoles (SLV). Large nuclear vacuoles are specific sperm alterations observed under high magnification, and their presence has been related to increased DNA fragmentation and denaturation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pregnancy
Started Jan 2013
Shorter than P25 for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2012
CompletedFirst Posted
Study publicly available on registry
November 16, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedNovember 18, 2014
November 1, 2014
1 year
November 12, 2012
November 17, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Pregnancy
Number of clinical pregnancy rate divided by the number of couples in which embryo transfer was performed
1 month
Study Arms (1)
MSOME
EXPERIMENTALCouples in which the sperm cells were analysed through MSOME
Interventions
A total of 200 spermatozoa of each sample will be analyzed under high magnification (x6600) and the incidence of SLV (sperm cells presenting at least one vacuole that occupied \> 13% of nuclear area) in each sample will be assessed.
Eligibility Criteria
You may qualify if:
- Couples undergoing intracytoplasmic sperm injection (ICSI) as result of male factor or tubal factor or unexplained infertility
- Women with regular menstrual cycles of 25-35 days
- Women with normal basal follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels
- Women with body mass index (BMI) less than 30 kg/m2
- Women with both ovaries and intact uterus
You may not qualify if:
- Women with polycystic ovaries syndrome
- Women with endometriosis
- Women with gynaecological/medical disorders
- Couples with any sexually transmitted disease
- Women who had received any hormone therapy for less than 60 days preceding the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sapientiae Institute
São Paulo, São Paulo, 04503-040, Brazil
Study Officials
- PRINCIPAL INVESTIGATOR
Edson Borges Jr., MD., PhD
Sapientiae Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2012
First Posted
November 16, 2012
Study Start
January 1, 2013
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
November 18, 2014
Record last verified: 2014-11